• Home
  • Pharmaceuticals and Healthcare
Dynamics in Post-pandemic Global Oncology Biosimilars Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Oncology Biosimilars Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ647373 | No. of Pages: 132 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Mar-2021 
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Oncology Biosimilars market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Oncology Biosimilars market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Monoclonal Antibody

Hematopoietic Agents

G-CSF

Others

Segmented by End User/Segment
Retail Pharmacies

Hospital Pharmacy

Online Pharmacy

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Teva Pharmaceutical Industries Ltd

STADA Arzneimittel AG

Sandoz International

Pfizer

Intas Pharmaceuticals

Dr. Reddy’s Laboratories

Celltrion

Biocon

BIOCAD

Apotex



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Oncology Biosimilars Market Status and Forecast (2016-2027)
        1.3.2 Global Oncology Biosimilars Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Oncology Biosimilars Supply by Company
    2.1 Global Oncology Biosimilars Sales Volume by Company
    2.2 Global Oncology Biosimilars Sales Value by Company
    2.3 Global Oncology Biosimilars Price by Company
    2.4 Oncology Biosimilars Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Oncology Biosimilars Market Status by Category
    3.1 Oncology Biosimilars Category Introduction
        3.1.1 Monoclonal Antibody

        3.1.2 Hematopoietic Agents

        3.1.3 G-CSF

        3.1.4 Others
    3.2 Global Oncology Biosimilars Market by Category
        3.2.1 Global Oncology Biosimilars Sales Volume by Category (2016-2021)
        3.2.2 Global Oncology Biosimilars Sales Value by Category (2016-2021)
        3.2.3 Global Oncology Biosimilars Price by Category (2016-2021)
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional Oncology Biosimilars Market Status by End User/Segment
    4.1 Oncology Biosimilars Segment by End User/Segment
        4.1.1 Retail Pharmacies

        4.1.2 Hospital Pharmacy

        4.1.3 Online Pharmacy
    4.2 Global Oncology Biosimilars Market by End User/Segment
        4.2.1 Global Oncology Biosimilars Sales Volume by End User/Segment (2016-2021)
        4.2.2 Global Oncology Biosimilars Sales Value by End User/Segment (2016-2021)
        4.2.3 Global Oncology Biosimilars Price by End User/Segment (2016-2021)
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global Oncology Biosimilars Market Status by Region
    5.1 Global Oncology Biosimilars Market by Region
        5.1.1 Global Oncology Biosimilars Sales Volume by Region
        5.1.2 Global Oncology Biosimilars Sales Value by Region
    5.2 North America Oncology Biosimilars Market Status
    5.3 Europe Oncology Biosimilars Market Status
    5.4 Asia Pacific Oncology Biosimilars Market Status
    5.5 Central & South America Oncology Biosimilars Market Status
    5.6 Middle East & Africa Oncology Biosimilars Market Status
6 North America Oncology Biosimilars Market Status
    6.1 North America Oncology Biosimilars Market by Country
        6.1.1 North America Oncology Biosimilars Sales Volume by Country (2016-2021)
        6.1.2 North America Oncology Biosimilars Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Oncology Biosimilars Market Status
    7.1 Europe Oncology Biosimilars Market by Country
        7.1.1 Europe Oncology Biosimilars Sales Volume by Country (2016-2021)
        7.1.2 Europe Oncology Biosimilars Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Oncology Biosimilars Market Status
   8.1 Asia Pacific Oncology Biosimilars Market by Country
        8.1.1 Asia Pacific Oncology Biosimilars Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific Oncology Biosimilars Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Oncology Biosimilars Market Status
    9.1 Central & South America Oncology Biosimilars Market by Country
        9.1.1 Central & South America Oncology Biosimilars Sales Volume by Country (2016-2021)
        9.1.2 Central & South America Oncology Biosimilars Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Oncology Biosimilars Market Status
    10.1 Middle East & Africa Oncology Biosimilars Market by Country
        10.1.1 Middle East & Africa Oncology Biosimilars Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa Oncology Biosimilars Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Oncology Biosimilars Manufacturing Cost Analysis
    11.5 Oncology Biosimilars Sales Channel and Distributors Analysis
        11.5.1 Oncology Biosimilars Sales Channel
        11.5.2 Oncology Biosimilars Distributors
    11.6 Oncology Biosimilars Downstream Major Buyers
12 Global Oncology Biosimilars Market Forecast by Category and by End User/Segment
    12.1 Global Oncology Biosimilars Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global Oncology Biosimilars Forecast by Category
        12.2.1 Global Oncology Biosimilars Sales Volume Forecast by Category
        12.2.2 Global Oncology Biosimilars Sales Value Forecast by Category
        12.2.3 Global Oncology Biosimilars Price Forecast by Category
    12.3 Global Oncology Biosimilars Forecast by End User/Segment
        12.3.1 Global Oncology Biosimilars Sales Volume Forecast by End User/Segment
        12.3.2 Global Oncology Biosimilars Sales Value Forecast by End User/Segment
        12.3.3 Global Oncology Biosimilars Price Forecast by End User/Segment
13 Global Oncology Biosimilars Market Forecast by Region/Country
    13.1 Global Oncology Biosimilars Market Forecast by Region (2022-2027)
        13.1.1 Global Oncology Biosimilars Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global Oncology Biosimilars Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Teva Pharmaceutical Industries Ltd

        14.1.1 Company Information
        14.1.2 Oncology Biosimilars Product Introduction
        14.1.3 Teva Pharmaceutical Industries Ltd
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 STADA Arzneimittel AG

        14.2.1 Company Information
        14.2.2 Oncology Biosimilars Product Introduction
        14.2.3 STADA Arzneimittel AG
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 Sandoz International

        14.3.1 Company Information
        14.3.2 Oncology Biosimilars Product Introduction
        14.3.3 Sandoz International
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Pfizer

        14.4.1 Company Information
        14.4.2 Oncology Biosimilars Product Introduction
        14.4.3 Pfizer
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Intas Pharmaceuticals

        14.5.1 Company Information
        14.5.2 Oncology Biosimilars Product Introduction
        14.5.3 Intas Pharmaceuticals
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Dr. Reddy’s Laboratories

        14.6.1 Company Information
        14.6.2 Oncology Biosimilars Product Introduction
        14.6.3 Dr. Reddy’s Laboratories
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.6.4 SWOT Analysis
    14.7 Celltrion

        14.7.1 Company Information
        14.7.2 Oncology Biosimilars Product Introduction
        14.7.3 Celltrion
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.7.4 SWOT Analysis
    14.8 Biocon

        14.8.1 Company Information
        14.8.2 Oncology Biosimilars Product Introduction
        14.8.3 Biocon
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.8.4 SWOT Analysis
    14.9 BIOCAD

        14.9.1 Company Information
        14.9.2 Oncology Biosimilars Product Introduction
        14.9.3 BIOCAD
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.9.4 SWOT Analysis
    14.10 Apotex

        14.10.1 Company Information
        14.10.2 Oncology Biosimilars Product Introduction
        14.10.3 Apotex
 Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.10.4 SWOT Analysis
15 Conclusion
16 Methodology


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com